ArticleBiometrics2023
Power analysis for cluster randomized trials with continuous coprimary endpoints.
Article in Biometrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 7 citations in OpenAlex.
- A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.Statistical methods in medical research · 2026Article
- Rank-based estimators of global treatment effects for cluster randomized trials with multiple endpoints on different scales.Statistical methods in medical research · 2025Article
- Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness-Implementation Studies.Statistics in medicine · 2025Article
- Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.Statistics in medicine · 2023Article
- Permutation-based multiple testing corrections forStatistics in medicine · 2023Article
- Power analyses for stepped wedge designs with multivariate continuous outcomes.Statistics in medicine · 2023Article
- Multiparametric Quantitative Imaging Biomarker as a Multivariate Descriptor of Health: A Roadmap.Academic radiology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 3 countries.
Funding
Abstract
Pragmatic trials evaluating health care interventions often adopt cluster randomization due to scientific or logistical considerations. Systematic reviews have shown that coprimary endpoints are not uncommon in pragmatic trials but are seldom recognized in sample size or power calculations. While methods for power analysis based on K (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.